Clinical Trial

YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study aims to determine the safety and maximum tolerated dose (MTD) of YMN-136 vaccine through a dose escalation trial, and to investigate whether YMN-136 vaccine can assist in the treatment of patients with metastatic colorectal cancer.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-07-30
notable Primary completion pushed: 2028-02-01 -> 2028-06-01 2026-07-30
minor Completion pushed: 2028-03-01 -> 2029-06-01 2026-07-30
Trial Details
NCT Number NCT07409805
Lead Sponsor West China Hospital
Conditions Colorectal Cancer
Enrollment 9 participants
Start Date 2026-05-06
Primary Completion 2028-06-01 (estimated)
Study Completion 2029-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-29